Herein, we report our identification of a novel de novo TAZ variant, causing a D75H substitution within the H(X)4D acyltransferase motif, in a BTHS patient presenting with cardiomyopathy, muscle wasting, short stature, and neutropenia. Here, TAFAZZIN is linked to neutropenia.